Artificial intelligence: a new field of knowledge for nephrologists?

Author:

Fayos De Arizón Leonor123,Viera Elizabeth R123,Pilco Melissa123,Perera Alexandre456,De Maeztu Gabriel7,Nicolau Anna8,Furlano Monica123,Torra Roser123ORCID

Affiliation:

1. Nephrology , Barcelona , Spain

2. Department, Fundació Puigvert; Institut , Barcelona , Spain

3. d'Investigacions Biomèdiques Sant Pau (IIB-Sant Pau); Departament de Medicina, Universitat Autònoma de Barcelona , Barcelona , Spain

4. Center for Biomedical Engineering Research (CREB), Universitat Politècnica de Barcelona (UPC) , Barcelona , , Biomaterials and Nanomedicine (CIBER-BBN), Madrid , , Esplugues de Llobregat, Barcelona , Spain

5. Spain; Networking Biomedical Research Centre in the subject area of Bioengineering , Barcelona , , Biomaterials and Nanomedicine (CIBER-BBN), Madrid , , Esplugues de Llobregat, Barcelona , Spain

6. Spain; Institut de Recerca Sant Joan de Déu , Barcelona , , Biomaterials and Nanomedicine (CIBER-BBN), Madrid , , Esplugues de Llobregat, Barcelona , Spain

7. IOMED , Barcelona , Spain

8. Neuroelectrics , Barcelona , Spain

Abstract

ABSTRACT Artificial intelligence (AI) is a science that involves creating machines that can imitate human intelligence and learn. AI is ubiquitous in our daily lives, from search engines like Google to home assistants like Alexa and, more recently, OpenAI with its chatbot. AI can improve clinical care and research, but its use requires a solid understanding of its fundamentals, the promises and perils of algorithmic fairness, the barriers and solutions to its clinical implementation, and the pathways to developing an AI-competent workforce. The potential of AI in the field of nephrology is vast, particularly in the areas of diagnosis, treatment and prediction. One of the most significant advantages of AI is the ability to improve diagnostic accuracy. Machine learning algorithms can be trained to recognize patterns in patient data, including lab results, imaging and medical history, in order to identify early signs of kidney disease and thereby allow timely diagnoses and prompt initiation of treatment plans that can improve outcomes for patients. In short, AI holds the promise of advancing personalized medicine to new levels. While AI has tremendous potential, there are also significant challenges to its implementation, including data access and quality, data privacy and security, bias, trustworthiness, computing power, AI integration and legal issues. The European Commission's proposed regulatory framework for AI technology will play a significant role in ensuring the safe and ethical implementation of these technologies in the healthcare industry. Training nephrologists in the fundamentals of AI is imperative because traditionally, decision-making pertaining to the diagnosis, prognosis and treatment of renal patients has relied on ingrained practices, whereas AI serves as a powerful tool for swiftly and confidently synthesizing this information.

Funder

Instituto de Salud Carlos III

EU-Next Generation, Mechanism

Fundació la Marató de TV3

FEDER

Ministry of Economy and Competitiveness

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3